The findings by Singhal and co-workers emphasized the need for more mechanistic studies to aid in a complete understanding of the complexity of PR and ERα crosstalk in breast cancer, in the drive to develop PR/ER co-therapies for ER-positive breast cancer. The gene discussed is PGR; the disease is breast cancer.